Login / Signup

Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study.

Raffaele NapoliAntonio NicolucciMonica LarosaMaria Chiara RossiRiccardo Candidonull null
Published in: Diabetes, obesity & metabolism (2024)
2BI are a valuable option to intensify GLP-1 RA therapy. Switching to Gla-300 versus Deg-100 was associated with greater HbA1c improvement.
Keyphrases
  • type diabetes
  • rheumatoid arthritis
  • cardiovascular disease
  • glycemic control
  • stem cells
  • insulin resistance
  • disease activity
  • metabolic syndrome
  • adipose tissue
  • systemic lupus erythematosus
  • cell therapy